CoCensys Names New Leader in a Series of Company Moves
- Share via
Daniel L. Korpolinski has been appointed president and chief executive of CoCensys Inc., a privately held biopharmaceutical company in Irvine. He succeeds Robert G. Neil, who will serve as chairman. Korpolinski was formerly president of Adria Laboratories, North America. Before that, he spent 24 years at Upjohn Co. In addition, CoCensys announced that Kelvin W. Gee has been appointed chief scientific officer and that Donald W. Ashbrook has been appointed vice president of scientific affairs.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
